Nuvasive Inc (NASDAQ:NUVA) Institutional Investors Sentiment

July 17, 2017 - By Maria Brooks

 Nuvasive Inc (NASDAQ:NUVA) Institutional Investors Sentiment

Sentiment for Nuvasive Inc (NASDAQ:NUVA)

Nuvasive Inc (NASDAQ:NUVA) institutional sentiment decreased to 0.93 in Q4 2016. Its down -0.58, from 1.51 in 2016Q3. The ratio fall, as 122 active investment managers opened new or increased stock positions, while 131 sold and decreased their equity positions in Nuvasive Inc. The active investment managers in our partner’s database now have: 53.03 million shares, up from 50.46 million shares in 2016Q3. Also, the number of active investment managers holding Nuvasive Inc in their top 10 stock positions increased from 4 to 6 for an increase of 2. Sold All: 37 Reduced: 94 Increased: 81 New Position: 41.

Nuvasive, Inc. is a medical device company. The company has market cap of $4.02 billion. The Firm focuses on developing minimally-disruptive surgical products and procedurally-integrated solutions for the spine surgery. It has a 80.51 P/E ratio. The Company’s product portfolio focuses on applications for spine fusion surgery, including biologics used to aid in the spinal fusion process.

About 317,710 shares traded. NuVasive, Inc. (NASDAQ:NUVA) has risen 33.31% since July 17, 2016 and is uptrending. It has outperformed by 16.61% the S&P500.

Analysts expect NuVasive, Inc. (NASDAQ:NUVA) to report $0.45 EPS on July, 25.They anticipate $0.05 EPS change or 12.50 % from last quarter’s $0.4 EPS. NUVA’s profit would be $23.08 million giving it 43.54 P/E if the $0.45 EPS is correct. After having $0.38 EPS previously, NuVasive, Inc.’s analysts see 18.42 % EPS growth.

Hood River Capital Management Llc holds 3.76% of its portfolio in NuVasive, Inc. for 640,690 shares. Sectoral Asset Management Inc owns 498,689 shares or 3.72% of their US portfolio. Moreover, Iguana Healthcare Management Llc has 2.82% invested in the company for 70,000 shares. The New York-based Pura Vida Investments Llc has invested 2.59% in the stock. Ghost Tree Capital Llc, a New York-based fund reported 150,000 shares.#img1#

Since January 1, 0001, it had 0 insider buys, and 4 insider sales for $4.72 million activity.

NuVasive, Inc. (NASDAQ:NUVA) Ratings Coverage

Ratings analysis reveals 88% of Nuvasive Inc.’s analysts are positive. Out of 16 Wall Street analysts rating Nuvasive Inc., 14 give it “Buy”, 0 “Sell” rating, while 2 recommend “Hold”. The lowest target is $56 while the high is $9000. The stock’s average target of $72.07 is -8.06% below today’s ($78.39) share price. NUVA was included in 25 notes of analysts from July 29, 2015. Canaccord Genuity upgraded the shares of NUVA in report on Tuesday, October 6 to “Buy” rating. Cowen & Co maintained the stock with “Outperform” rating in Wednesday, April 27 report. Morgan Stanley initiated NuVasive, Inc. (NASDAQ:NUVA) on Monday, September 14 with “Equal-Weight” rating. The firm has “Buy” rating by Cowen & Co given on Wednesday, June 28. Bank of America upgraded NuVasive, Inc. (NASDAQ:NUVA) on Friday, December 11 to “Neutral” rating. The stock has “Overweight” rating by Barclays Capital on Friday, May 27. As per Thursday, June 29, the company rating was maintained by Jefferies. The rating was maintained by Leerink Swann with “Buy” on Tuesday, September 1. BMO Capital Markets upgraded the shares of NUVA in report on Tuesday, October 6 to “Outperform” rating. JP Morgan upgraded the stock to “Overweight” rating in Wednesday, July 13 report.

More news for NuVasive, Inc. (NASDAQ:NUVA) were recently published by: Seekingalpha.com, which released: “Innovation And Execution A Powerful Combination For NuVasive” on June 21, 2017. Prnewswire.com‘s article titled: “NuVasive Leading Sponsor Of IMAST 2017 And Hosting Workshops Featuring …” and published on July 10, 2017 is yet another important article.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.